ConductScience.org, home

Paper2234840

Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema.

Olk RJ. Ophthalmology, 1990. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema. Papers, record 2234840. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2234840

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema.
PubMed
Journal
Ophthalmology
PubMed
Year
1990
PubMed
Publication types
Case Reports, Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
3.92
iCite
Revised in PubMed
2019-07-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Olk RJR J

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 1Major topic
Diabetes Mellitus, Type 2Major topic
LasersMajor topic
Light CoagulationMajor topic
Macular EdemaMajor topic
Adult
Aged
Aged, 80 and over
Argon
Female
Follow-Up Studies
Fundus Oculi
Humans
Krypton
Male
Middle Aged
Prognosis
Prospective Studies
Visual Acuity

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
34487257Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema.Curr Diab Rep2021https://conductscience.org/library/papers/34487257PubMed
30505117Treatment before macular grid in patients of diabetic macular edema.Oman J Ophthalmol2018https://conductscience.org/library/papers/30505117PubMed
30505116Evaluation of intravitreal bevacizumab as monotherapy and in combination with macular grid laser photocoagulation in diffuse diabetic macular edema.Oman J Ophthalmol2018https://conductscience.org/library/papers/30505116PubMed
30320466Monotherapy laser photocoagulation for diabetic macular oedema.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/30320466PubMed
25949072Recent developments in laser treatment of diabetic retinopathy.Middle East Afr J Ophthalmol2015https://conductscience.org/library/papers/25949072PubMed
24379924Diabetic macular edema: New promising therapies.World J Diabetes2013https://conductscience.org/library/papers/24379924PubMed
22587512Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review.Curr Diabetes Rev2012https://conductscience.org/library/papers/22587512PubMed
17420366Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.Arch Ophthalmol2007https://conductscience.org/library/papers/17420366PubMed
17077114Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema.Br J Ophthalmol2007https://conductscience.org/library/papers/17077114PubMed
16779572Vitrectomy seems to be beneficial for advanced diffuse diabetic macular oedema not responding to laser treatment.Int Ophthalmol2005https://conductscience.org/library/papers/16779572PubMed
16601980Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c).Graefes Arch Clin Exp Ophthalmol2006https://conductscience.org/library/papers/16601980PubMed
15615751Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema.Br J Ophthalmol2005https://conductscience.org/library/papers/15615751PubMed
15317711Subthreshold micropulse diode laser treatment in diabetic macular oedema.Br J Ophthalmol2004https://conductscience.org/library/papers/15317711PubMed
10896359Grid photocoagulation for focal diabetic macular edema with focal leaks and hard exsudates involving the peri-foveolar area.Doc Ophthalmol1999https://conductscience.org/library/papers/10896359PubMed
8045437Spontaneous evolution and photocoagulation of diabetic cystoid macular edema.Graefes Arch Clin Exp Ophthalmol1994https://conductscience.org/library/papers/8045437PubMed
7742274Diode laser photocoagulation for diabetic macular oedema.Br J Ophthalmol1995https://conductscience.org/library/papers/7742274PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2234840

GET https://conductscience.org/api/papers/v1/2234840/authors